Flagship explainer
How Amphastar Pharmaceuticals, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $720M | 100% |
| |
| Cost of revenue | $364M | 51% |
|
| $356M | 49% |
| |
| $140M | 20% |
| |
| Income before tax | $124M | 17% |
|
| Income tax | $25.5M | 4% |
|
| $98.1M | 14% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001297184-26-000009